• No results found

Cover Page The handle

N/A
N/A
Protected

Academic year: 2021

Share "Cover Page The handle"

Copied!
6
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

The handle http://hdl.handle.net/1887/56256 holds various files of this Leiden University dissertation

Author: Zom, Gijs

Title: Adjuvant-conjugated peptide vaccines for immunotherapy of cancer

Date: 2017-10-19

(2)

Adjuvant-conjugated peptide vaccines for immunotherapy of cancer

Gijs Zom

(3)

2

The research described in this thesis was performed at the Department of Immunohematology and Bloodtransfusion of the Leiden University Medical Center in The Netherlands. This work was supported by the Dutch Cancer Society (UL2007-3906). Printing of this thesis was sponsored by ISA Pharmaceuticals and Greiner Bio-One.

Lay-out: Gijs Zom

Art director: Suzette van Maanen Thesis printing: Printservice Ede ISBN: 978-94-92679-14-7

All rights reserved. Nothing from this thesis may be reproduced in any form without permission from the author.

Copyright © 2017 G.G.P. Zom

(4)

Adjuvant-conjugated peptide vaccines for immunotherapy of cancer

Proefschrift

ter verkrijging van

de graad van Doctor aan de Universiteit Leiden, op gezag van Rector Magnificus prof. mr. C.J.J.M. Stolker,

volgens besluit van het College voor Promoties te verdedigen op

donderdag 19 oktober 2017, klokke 13.45 uur

door

Gijsbertus Gerardus Petrus Zom

Geboren te Breda in 1984

(5)

4

Leden promotiecommissie Prof. Dr. A. Geluk

Prof. Dr. H. Ovaa

Prof. Dr. R.E.M. Toes

Prof. Dr. T.D. de Gruijl; VUMC Amsterdam

Prof. Dr. Y. van Kooyk; VUMC Amsterdam

(6)

Table of contents

Chapter 1

Introduction: TLR ligand-peptide conjugate vaccines: toward clinical application 7

Chapter 2 Efficient induction of antitumor immunity by synthetic Toll-like receptor-ligand 35

peptide conjugates Chapter 3 N-Tetradecylcarbamyl Lipopeptides as Novel Agonists for Toll-like Receptor 2 53

Chapter 4 Novel TLR2-binding adjuvant induces enhanced T cell responses and tumor 71

eradication Chapter 5 TLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor- 93

draining lymph node T cells of cervical cancer patients Chapter 6 Synergistic DC activation by synthetic peptide-based conjugates triggering 115

both TLR2 and NOD2 Chapter 7 Summary and general discussion 135

Nederlandse samenvatting 152

Dankwoord 157

Curriculum vitae 161

List of publications 163

Referenties

GERELATEERDE DOCUMENTEN

We show that the TLR2-L SLP conjugates induce significant activation of HPV16-specific CD8 + and CD4 + T cells and robust expression of IFNγ and/or IL-2 by ex vivo

Tenslotte hebben we een nieuwe vorm van conjugaat vaccins ontwikkeld, dat niet alleen bestaat uit een peptide en TLR2-ligand Pam3CSK4, maar ook uit een ligand genaamd MDP

Chapter 5 explores the optimal time-window to start immunotherapy with the HPV16 Synthetic Long Peptide (HPV16-SLP) vaccine, in combination with chemotherapy. The combination

pertussis clearance from the respiratory tract after intranasal challenge, gene expression profiles in draining lymph nodes and lungs, and cytokine profiles and antibody responses

Chapter 5 Toll-like receptor triggering augments activation of human mast cells by anti-citrullinated protein

Chapter 4 - Splice variants of Tissue Factor promote monocyte-endothelial interactions by triggering the expression of cell adhesion molecules via integrin ligation 55 Chapter 5 -

Chapter 7 Improved sentinel lymph node biopsy in melanoma patients by combining radioactive and fl uorescence guidance 111 Chapter 8 Optimization of sentinel lymph node mapping

Synthesis of trifunctional mannosylated peptide antigen conjugates targeting DC-SIGN and